AU6955294A - Agents for the prevention and treatment of parkinson's disease - Google Patents

Agents for the prevention and treatment of parkinson's disease

Info

Publication number
AU6955294A
AU6955294A AU69552/94A AU6955294A AU6955294A AU 6955294 A AU6955294 A AU 6955294A AU 69552/94 A AU69552/94 A AU 69552/94A AU 6955294 A AU6955294 A AU 6955294A AU 6955294 A AU6955294 A AU 6955294A
Authority
AU
Australia
Prior art keywords
parkinson
disease
prevention
agents
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69552/94A
Inventor
Johanna E. Bergmann
Rick E. Preddie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2086576 external-priority patent/CA2086576A1/en
Application filed by Individual filed Critical Individual
Publication of AU6955294A publication Critical patent/AU6955294A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU69552/94A 1992-12-31 1993-12-30 Agents for the prevention and treatment of parkinson's disease Abandoned AU6955294A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2086576 1992-12-31
CA 2086576 CA2086576A1 (en) 1992-12-31 1992-12-31 Potential target for an immunotherapeutic approach to stop parkinson's disease in humans: cdna and protein structure for a putative activator of human dopamine receptor and human brain ca2+ channel protein reconstructed from the antisense strand of the human app gene
US13216993A 1993-10-06 1993-10-06
US132169 1993-10-06
PCT/EP1993/003722 WO1994015967A1 (en) 1992-12-31 1993-12-30 Agents for the prevention and treatment of parkinson's disease

Publications (1)

Publication Number Publication Date
AU6955294A true AU6955294A (en) 1994-08-15

Family

ID=25675788

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69552/94A Abandoned AU6955294A (en) 1992-12-31 1993-12-30 Agents for the prevention and treatment of parkinson's disease

Country Status (2)

Country Link
AU (1) AU6955294A (en)
WO (1) WO1994015967A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1538163A3 (en) * 2000-11-01 2005-06-15 Insight Biotechnology Limited Phosphorylated Amyloid-Beta 1-43 Protein and its use in the treatment of Alzheimer's disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005138A1 (en) * 1988-11-08 1990-05-17 The Children's Medical Center Corporation Cytotoxic amyloid precursors and screening assays using them

Also Published As

Publication number Publication date
WO1994015967A1 (en) 1994-07-21

Similar Documents

Publication Publication Date Title
HU9302551D0 (en) Compounds having effect against hypoglycemia and alzheimer's disease
AU7397094A (en) Prevention and treatment of alzheimer's disease
AU6905391A (en) Methods and compositions for the treatment of hodgkin's disease
GR980300033T1 (en) Compositions for the treatment of dermatological disorders and methods for their use
AU4997093A (en) Treatment of alzheimer's disease and modulation of immune system with delta5-androstenes
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
IT1271567B (en) PROCEDURE FOR THE FURTHER TREATMENT OF SALCICCE
IL104755A0 (en) Treatment of glaucoma
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
AU8185491A (en) Treatment of disease
ZA924128B (en) New combination preparations for treatment of Parkinson's disease.
AU6955294A (en) Agents for the prevention and treatment of parkinson's disease
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
IL104756A0 (en) Composition for the treatment of glaucoma
IL111017A0 (en) Transdermal device containing (e)-2-(p-fluorophenethyl)-3-fluoroallylamine and its use for the treatment of alzheimer's disease
GB9516572D0 (en) Prevention and/or treatment of disease
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU7699496A (en) Use of 2-iminobenzothiazolines for treating parkinson's disease and parkinsonian syndromes
AU5397994A (en) Treatment of skin disorders